• Please be aware that ICL's Laboratory Information System is undergoing a 5-hour scheduled downtime on Sunday, June 22 beginning at 20:00 EST.
• Due to ongoing labour disputes, Canada Post services will be suspended, which may impact some of our FIT and Integrative Laboratory Services (ILS) clients. Read more
Back to Test Catalogue

Chlordiazepoxide LC-MS/MS, Serum

Test ID: CLDIAZSM S

Test

Aliases/Synonyms

Librium

Method

LC-MS/MS

Report Includes

Chlordiazepoxide; Nordiazepam

Specimens

Gel-separator tubes are not acceptable; Serum

Test Location

St. Michael's Hospital, 30 Bond Street, Toronto ON M5B 1W8

Test Version

13-Jan-2023

Specimen

Specimens

Gel-separator tubes are not acceptable; Serum

Collection Containers

Red top (no additive)

Sample Volume

1 mL

Specimen Comment

Avoid gel-separator tubes.

Collection & Handling

Handling Information

Store and submit specimen protected from light in an amber vial.
Separate and aliquot within 2 hours. Store and send cold or frozen.

Stability

Ambient 24 hours
Refrigerated 14 days
Frozen 14 days

Rejection Criteria

Specimen Gel tube or not protected from light

Test Version

13-Jan-2023

Performance / Interpretation

Method

LC-MS/MS

Turnaround Time

12 days

Results

Name Units Reference Range Conversion Factor
Chlordiazepoxide ng/mL
  • Therapeutic: 400 - 3000
  • Toxic: > 3500
nmol/L x 0.287
Nordiazepam ng/mL
  • Therapeutic: 100 - 500
  • Toxic: > 500
nmol/L x 0.266
Therapeutic ranges based on Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: update 2017 and Tietz Textbook of Clinical Chemistry and Molecular Diagnostics 6th ed pp. 1808.

Test Location

St. Michael's Hospital, 30 Bond Street, Toronto ON M5B 1W8

Test Version

13-Jan-2023

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
CHDIAZSM S 64774Chlordiazepam ng/mL
64775Nordiazepam ng/mL

Test Version

13-Jan-2023